Jump to content

India has given emergency use authorization for a COVID-19 antibody drug cocktail by Roche

AndhraPickles

By AndhraPickles
in Discussions

 Share

Recommended Posts

AndhraPickles Sr. Hero

AndhraPickles

Posted
Posted

India has given emergency use authorization for a COVID-19 antibody drug cocktail developed by Roche (ROG.S) and Regeneron (REGN.O), expanding its arsenal of drugs to battle a massive second wave of infections.

The decision was taken based on data filed with the U.S. regulators and the scientific opinion of a European regulatory panel, Roche's India distribution partner for the drug, Cipla (CIPL.NS), said on Wednesday.

The therapy is a cocktail of two antibodies Casirivimab and Imdevimab, which are synthetically manufactured copies of antibodies that the body produces after an infection.

It has been shown to reduce hospitalizations in COVID-19 patients who are at a high risk of developing severe illness.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
 Share
Go to topic listing
×
×
  • Create New...